. . . . . . . . . "When we asked about the long-term treatment of BD, after having excluded from the analyses the 3 SGAs with a European indication for maintenance BD treatment (aripiprazole, olanzapine, and quetiapine), asenapine was considered either “highly appropriate” or “appropriate” by 44.6% of the respondents, while other off-label SGAs (clozapine, paliperidone, risperidone, ziprasidone) were mostly considered inappro- priate for maintenance bipolar treatment" . . . . . . "Adults" . . "2021-08-17T13:35:49.030571"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "IQK9u9OLH0mCXBYr1jkEIDsC+sVqHSbyr56NsNTc1W6j4V/nJSdRR1iI95x+x84IXmdYA4SWVac594zDWVl5us1ejyGQcreRTRSIQFca2LFJqPQQO8JvwJ0v9ffi/vfEqW2ZS8nXAZIiZQBUfh3FROO6EkkaMSs2ivayzOvx77I=" . . "2021-08-17T13:35:49.030571"^^ . . .